Serum fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 29, Issue 12, 2013, Pages 1036-1039

  Enli, Yasar ^a   Fenkci, Semin Melahat ^b   Fenkci, Veysel ^a   Oztekin, Ozer ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b Cerrahi Hospital   (Turkey)

Author keywords

Fetuin A; Insulin resistance; Oxidative stress; PCOS

Indexed keywords

ANDROGEN; FETUIN A; FOLLITROPIN; GLUCOSE; GLUTATHIONE; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; MALONALDEHYDE; MYELOPEROXIDASE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SUPEROXIDE DISMUTASE; TESTOSTERONE;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPENDENT VARIABLE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INDEPENDENT VARIABLE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; OVARIAN HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ALPHA-2-HS-GLYCOPROTEIN; ANDROGENS; BLOOD GLUCOSE; DYSLIPIDEMIAS; FEMALE; FOLLICLE STIMULATING HORMONE; GLUTATHIONE; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; LUTEINIZING HORMONE; MALONDIALDEHYDE; OXIDATIVE STRESS; PEROXIDASE; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84887249082     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.829442     Document Type: Article

References (27)

1. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85: 2434-8.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18: 774-800.
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1165-74.
4. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001;86:66-71.
5. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010;8:41.
6. Stuart D, Nagamani M. Acute augmentation of plasma androstenedione and dehydroepiandrosterone by euglycemic insulin infusion: evidence for a direct effect of insulin on ovarian steroidogenesis. In: Dunaif A, Givens J, Haseltine F, Merriam G, editors. Current issues in endocrinology and metabolism: polycystic ovary syndrome. Cambridge: Blackwell; 1992:279-88.
7. Song AY, Xu M, Bi YF, et al. Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults. PLOS One 2011;6:e19228.
8. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000;164:87-98.
9. Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002;51:2450-8.
10. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence Lancet 1994;344:721-4.
11. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
12. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123-7.
13. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2003;81:19-25.
14. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7.
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
16. Geloneze B, Vasques AC; BRAMS Investigators, et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol 2009;53:281-7.
17. Okhawa H, Ohishi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-8.
18. Winterbourn CC, Hawkings RE, Brian M, Carrel RW. The estimation of red cells superoxide dismutase activity. J Lab Clin Med 1975;85:337-42.
19. Enli Y, Oztekin O, Pinarbasili RD. The nitroxide tempol has similar antioxidant effects as physiological levels of 17betaoestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney. Scand J Clin Lab Invest 2009;69:526-34.
20. Knight KR, Zhang B, Morrison WA, Stewart AG. Ischaemia-reperfusion injury in mouse skeletal muscle is reduced by N-nitro-L-arginine methyl ester and dexamethasone. Eur J of Pharmacol 1997;332:273-8.
21. Ix JH, Chertow GM, Shlipak MG, et al. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:2533-9.
22. Gulhan I, Bozkaya G, Oztekin D, et al. Serum Fetuin-A levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 286:1473-6.
23. Barbieri RL. Insulin stimulates androgen accumulation in incubations of minced porcine theca. Gynecol Obstet Invest 1994;37: 265-9.
24. Nakazato T, Sagawa M, Yamato K, et al. Myeloperoxidase is a key regulator of oxidative stress-mediated apoptosis in myeloid leukemic cells. Clin Cancer Res 2007;13:5436-45.
25. Zhang Y, Zanotti I, Reilly MP, et al. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003;108:661-3.
26. Rizzo M, Kotur-Stevuljevic J, Berneis K, et al. Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 2009; 153:217-23.
27. Chen HY, Chiu YL, Hsu SP, et al. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients. Eur J Endocrinol 2009;160:777-83.